Health
Remdesivir may only provide modest benefit against ‘moderate’ COVID-19 – Medical Xpress
(HealthDay)—The antiviral drug remdesivir has been one of the few treatments that’s seemed to help curb death rates in COVID-19 patients so ill that they need a ventilator.
by E.j. Mundell, Healthday Reporter (HealthDay)The antiviral drug remdesivir has been one of the few treatments that’s seemed to help curb death rates in COVID-19 patients so ill that they need a ventilator.
But a new study finds the drug might not be as effective for ‘moderate’ cases of COVID-19patients hospitalized and perhaps needing oxygen to breathe, but not requiring a ventilator.
The study of nearly 600 such patients found that those who got a five-day course of remdesivir had a “statis…
-
Noosa News20 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General20 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News12 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General15 hours agoVigils mark Israel attack anniversary, Gaza death toll